Synthesis and Characterization of Ru(II)-DMSO-Cl-Chalcone Complexes: DNA Binding, Nuclease, and Topoisomerase II Inhibitory Activity

被引:64
作者
Gaur, Ruchi [1 ]
Mishra, Lallan [1 ]
机构
[1] Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India
关键词
RUTHENIUM(II) COMPLEXES; ANTICANCER ACTIVITY; LIGANDS; REDOX; THIOSEMICARBAZONES; INTERCALATION; POTENTIALS; CHALCONES; CHEMISTRY; CLEAVAGE;
D O I
10.1021/ic202440r
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The complexes of type cis-[Ru(S-DMSO)(3)(R-CO-CH=CH-R')Cl] (R = 2-hydroxyphenyl for all, R' = phenyl 1, naphthyl 2, anthracenyl 3, thiophene 4, 3-methyl thiophene 5) are synthesized and characterized using spectroscopic (IR, H-1 and C-13 NMR, and UV-vis) and single crystal X-ray diffraction techniques. Their crystal structures show the formation of both intermolecular and intramolecular H-bonding. The molecular assembly of complex 5 using secondary interactions provides a butterfly structure. The binding of complexes with calf thymus DNA is monitored using UV-vis spectral titrations. The binding interaction of complexes 1, 2, and 3 with DNA increases with increasing conjugation of aromatic rings. However, complexes 4 and 5 interact with DNA strongly. The emission from ethidium bromide (EB) bound DNA recorded in phosphate buffer solution (pH = 7.2) decreases by incremental addition of solution of the complexes. The complexes 4 and 5 (100 mu M) bind with the minor groove of DNA and cleave double-stranded pBR322 DNA significantly even in the absence of an activator. In the presence of H2O2, they cleave supercoiled DNA via oxidative pathway even at lower concentration (20 mu M). Both complexes 4 and 5 inhibit topoisomerase II activity with IC50 values of 18 and 13. These values suggest that 4 and 5 are potential topoisomerase II inhibitors as compared to some of known inhibitors like novobiocin and etoposide.
引用
收藏
页码:3059 / 3070
页数:12
相关论文
共 65 条
[1]  
Aldrich-Wright J.R., 1998, RRD INORG CHEM, V1, P13
[2]   CIS-DIHALOTETRAKIS(DIMETHYL SULFOXIDE)RUTHENIUM(II) AND TRANS-DIHALOTETRAKIS(DIMETHYL SULFOXIDE)RUTHENIUM(II) COMPLEXES (RUX2(DMSO)4, X = CL, BR) - SYNTHESIS, STRUCTURE, AND ANTITUMOR-ACTIVITY [J].
ALESSIO, E ;
MESTRONI, G ;
NARDIN, G ;
ATTIA, WM ;
CALLIGARIS, M ;
SAVA, G ;
ZORZET, S .
INORGANIC CHEMISTRY, 1988, 27 (23) :4099-4106
[3]   Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].
Ang, Wee Han ;
Dyson, Paul J. .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018
[4]   Light-induced anticancer activity of [RuCl2(DMSO)4] complexes [J].
Brindell, M ;
Kulis, E ;
Elmroth, SKC ;
Urbanska, K ;
Stochel, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7298-7304
[5]   DNA binding studies of ruthenium(II) complexes containing asymmetric tridentate ligands [J].
Chao, H ;
Mei, WJ ;
Huang, QW ;
Ji, LN .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2002, 92 (3-4) :165-170
[6]   Synthesis, DNA binding, photo-induced DNA cleavage and cytotoxicity studies of europium(III) complexes [J].
Chen, Gong-Jun ;
Qiao, Xin ;
Tian, Jin-Lei ;
Xu, Jing-Yuan ;
Gu, Wen ;
Liu, Xin ;
Yan, Shi-Ping .
DALTON TRANSACTIONS, 2010, 39 (44) :10637-10643
[7]   Non-platinum chemotherapeutic metallopharmaceuticals [J].
Clarke, MJ ;
Zhu, FC ;
Frasca, DR .
CHEMICAL REVIEWS, 1999, 99 (09) :2511-2533
[8]   Ruthenium metallopharmaceuticals (vol 232, pg 69, 2002) [J].
Clarke, MJ .
COORDINATION CHEMISTRY REVIEWS, 2003, 236 (1-2) :207-+
[9]   Stacking surface effect in the DNA intercalation of some polypyridine platinum(II) complexes [J].
Cusumano, M ;
Di Pietro, ML ;
Giannetto, A .
INORGANIC CHEMISTRY, 1999, 38 (08) :1754-1758
[10]   Organolithium mediated synthesis of prenylchalcones as potential inhibitors of chemoresistance [J].
Daskiewicz, JB ;
Comte, G ;
Barron, D ;
Di Pietro, A ;
Thomasson, F .
TETRAHEDRON LETTERS, 1999, 40 (39) :7095-7098